Ticker Details
Bicara Therapeutics Inc. Common Stock
IPO Date:	September 13, 2024
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$1.95B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.64 | 4.19%
Avg Daily Range (30 D):	$0.64 | 2.66%
Avg Daily Range (90 D):	$0.64 | 3.00%

Institutional Daily Volume
Avg Daily Volume:	.49M
Avg Daily Volume (30 D):	.63M
Avg Daily Volume (90 D):	.5M

Trade Size
Avg Trade Size (Sh.):	70
Avg Trade Size (Sh.) (30 D):	63
Avg Trade Size (Sh.) (90 D):	57

Institutional Trades
Total Institutional Trades:	570
Avg Institutional Trade:	$1.68M
Avg Institutional Trade (30 D):	$2.54M
Avg Institutional Trade (90 D):	$2.06M
Avg Institutional Trade Volume:	.1M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$1.97M
Avg Closing Trade (30 D):	$5.24M
Avg Closing Trade (90 D):	$2.9M
Avg Closing Volume:	109.4K

News

Jun 13, 2026 @ 5:01 AM What Does the Bicara Therapeutics CEO's Sale of 15... Source: Robert Izquierdo

Feb 26, 2026 @ 9:01 PM Bicara Therapeutics Announces Closing of Oversubsc... Source: Globe Newswire

Feb 25, 2026 @ 4:13 AM Bicara Therapeutics Announces Pricing of $150 Mill... Source: Na

Feb 24, 2026 @ 9:01 PM Bicara Therapeutics Announces Proposed Public Offe... Source: Globe Newswire

Dec 15, 2025 @ 1:00 PM Bicara Therapeutics to Present at the J.P. Morgan ... Source: Claire Mazumdar

Financials
	TTM	Q1 2026	Q4 2025
Basic EPS	$-2.78	$-.93	$-.68
Diluted EPS	$-2.78	$-.93	$-.68
Revenue	$M	$M	$M
Gross Profit
Net Income / Loss	$-157.32M	$-56.21M	$-37.39M
Operating Income / Loss	$-174.06M	$-60.24M	$-41.12M
Cost of Revenue
Net Cash Flow	$-166.25M	$226.78M	$-74.99M
PE Ratio